Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy

Kyung Ah Kim, Mi Suk Park, Hyun Jun Ji, Junyong Park, KwangHyub Han, Myeong Jin Kim, Ki Whang Kim

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose To assess whether MR perfusion and diffusion parameters taken before concurrent chemoradiotherapy (CCRT) are useful imaging biomarkers for predicting progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC). Materials and Methods Twenty patients with locally advanced HCC who had no treatment before CCRT underwent dynamic contrast-enhanced (DCE) and diffusion-weighted MRI. Mean values of the volume transfer constant (K trans), reflex constant (Kep), extravascular extracellular volume fraction (Ve) and the apparent diffusion coefficient (ADC) were estimated on a region of interest. The best cutoff value for each factor was assessed to differentiate between patients who had PFS shorter or longer than the median PFS. Patients were dichotomized in terms of the cutoff value. The survival outcome of the two groups and the predictive ability of each factor on PFS were evaluated. Results Median time to PFS was 179 days. The best cutoff values for ADC, Ktrans, Kep, and Ve was 1.008 × 10-3 mm2 s-1, 0.108 min-1, 0.570 min-1, and 0.298%. Patients with higher ADC had significantly longer PFS than those with lower ADC(P < 0.0001). Conclusion The ADC of HCC acquired before CCRT correlated with PFS and was valuable in the prediction of the clinical outcome of HCC treated with CCRT.

Original languageEnglish
Pages (from-to)286-292
Number of pages7
JournalJournal of Magnetic Resonance Imaging
Volume39
Issue number2
DOIs
Publication statusPublished - 2014 Feb 1

Fingerprint

Diffusion Magnetic Resonance Imaging
Chemoradiotherapy
Disease-Free Survival
Hepatocellular Carcinoma
Perfusion
Aptitude
Reflex
Biomarkers
Survival

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{a0468cc36d934a328bcd7041650bfc34,
title = "Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy",
abstract = "Purpose To assess whether MR perfusion and diffusion parameters taken before concurrent chemoradiotherapy (CCRT) are useful imaging biomarkers for predicting progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC). Materials and Methods Twenty patients with locally advanced HCC who had no treatment before CCRT underwent dynamic contrast-enhanced (DCE) and diffusion-weighted MRI. Mean values of the volume transfer constant (K trans), reflex constant (Kep), extravascular extracellular volume fraction (Ve) and the apparent diffusion coefficient (ADC) were estimated on a region of interest. The best cutoff value for each factor was assessed to differentiate between patients who had PFS shorter or longer than the median PFS. Patients were dichotomized in terms of the cutoff value. The survival outcome of the two groups and the predictive ability of each factor on PFS were evaluated. Results Median time to PFS was 179 days. The best cutoff values for ADC, Ktrans, Kep, and Ve was 1.008 × 10-3 mm2 s-1, 0.108 min-1, 0.570 min-1, and 0.298{\%}. Patients with higher ADC had significantly longer PFS than those with lower ADC(P < 0.0001). Conclusion The ADC of HCC acquired before CCRT correlated with PFS and was valuable in the prediction of the clinical outcome of HCC treated with CCRT.",
author = "Kim, {Kyung Ah} and Park, {Mi Suk} and Ji, {Hyun Jun} and Junyong Park and KwangHyub Han and Kim, {Myeong Jin} and Kim, {Ki Whang}",
year = "2014",
month = "2",
day = "1",
doi = "10.1002/jmri.24161",
language = "English",
volume = "39",
pages = "286--292",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy. / Kim, Kyung Ah; Park, Mi Suk; Ji, Hyun Jun; Park, Junyong; Han, KwangHyub; Kim, Myeong Jin; Kim, Ki Whang.

In: Journal of Magnetic Resonance Imaging, Vol. 39, No. 2, 01.02.2014, p. 286-292.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy

AU - Kim, Kyung Ah

AU - Park, Mi Suk

AU - Ji, Hyun Jun

AU - Park, Junyong

AU - Han, KwangHyub

AU - Kim, Myeong Jin

AU - Kim, Ki Whang

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Purpose To assess whether MR perfusion and diffusion parameters taken before concurrent chemoradiotherapy (CCRT) are useful imaging biomarkers for predicting progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC). Materials and Methods Twenty patients with locally advanced HCC who had no treatment before CCRT underwent dynamic contrast-enhanced (DCE) and diffusion-weighted MRI. Mean values of the volume transfer constant (K trans), reflex constant (Kep), extravascular extracellular volume fraction (Ve) and the apparent diffusion coefficient (ADC) were estimated on a region of interest. The best cutoff value for each factor was assessed to differentiate between patients who had PFS shorter or longer than the median PFS. Patients were dichotomized in terms of the cutoff value. The survival outcome of the two groups and the predictive ability of each factor on PFS were evaluated. Results Median time to PFS was 179 days. The best cutoff values for ADC, Ktrans, Kep, and Ve was 1.008 × 10-3 mm2 s-1, 0.108 min-1, 0.570 min-1, and 0.298%. Patients with higher ADC had significantly longer PFS than those with lower ADC(P < 0.0001). Conclusion The ADC of HCC acquired before CCRT correlated with PFS and was valuable in the prediction of the clinical outcome of HCC treated with CCRT.

AB - Purpose To assess whether MR perfusion and diffusion parameters taken before concurrent chemoradiotherapy (CCRT) are useful imaging biomarkers for predicting progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC). Materials and Methods Twenty patients with locally advanced HCC who had no treatment before CCRT underwent dynamic contrast-enhanced (DCE) and diffusion-weighted MRI. Mean values of the volume transfer constant (K trans), reflex constant (Kep), extravascular extracellular volume fraction (Ve) and the apparent diffusion coefficient (ADC) were estimated on a region of interest. The best cutoff value for each factor was assessed to differentiate between patients who had PFS shorter or longer than the median PFS. Patients were dichotomized in terms of the cutoff value. The survival outcome of the two groups and the predictive ability of each factor on PFS were evaluated. Results Median time to PFS was 179 days. The best cutoff values for ADC, Ktrans, Kep, and Ve was 1.008 × 10-3 mm2 s-1, 0.108 min-1, 0.570 min-1, and 0.298%. Patients with higher ADC had significantly longer PFS than those with lower ADC(P < 0.0001). Conclusion The ADC of HCC acquired before CCRT correlated with PFS and was valuable in the prediction of the clinical outcome of HCC treated with CCRT.

UR - http://www.scopus.com/inward/record.url?scp=84892808041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892808041&partnerID=8YFLogxK

U2 - 10.1002/jmri.24161

DO - 10.1002/jmri.24161

M3 - Article

VL - 39

SP - 286

EP - 292

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 2

ER -